Skip to main content

Table 3 Univariate analysis for luminal types (ILC and IDC, analysis of the split times)

From: Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma

  0–5 years of follow-up 5 years to end of follow-up
Variable: pathology type HR (95 % CI) P-value HR (95 % CI) P-value
DFS     
 IDC 1.0   1.0  
 ILC 1.32(0.64–2.72) 0.440 7.42(2.94–18.74) <0.001
OS     
 IDC 1.0   1.0  
 ILC 2.74(0.95–7.91) 0.051 2.09(0.48–9.01) 0.308
  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DFS disease free survival, OS overall survival, HR hazard ratio, 95 % CI 95 % confidence interval